SIML Simlatus Corp

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc.

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc.

San Francisco, California, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the company’s diversity includes other subsidiaries, such as Satel Group, a premier high-rise DirecTV provider for the financial commercial and residential metropolitan San Francisco Bay area, and Simlatus, a manufacturer of audio/video products that currently sells to DirecTV, CBS, Fox News and Warner Bros; announces its second Purchase Order to manufacture 6 Cold Water CBD/HEMP Extraction Systems in the amount of $4,320,000.  

Richard Hylen, Chairman and CEO, stated, “We received another commercial purchase order from Brand House Ventures Inc. on July 10, 2019 to manufacture 6 Cold-Water CBD/HEMP Extraction Systems for one of their European customers in the amount of $4,320,000.”

Mr. Hylen further stated, “We are targeting the pharmaceutical markets. With twice as many citizens as the United State and Canada combined, Europe could becomelegal cannabis market over the next five years. The second edition of the European Cannabis Report – produced by London-based advisory group Prohibition Partners – suggests that with 12% of the continent’s 739 million people being either ‘irregular and intensive’ cannabis consumers, Europe’s annual overall marijuana market will reach 56.2 billion Euros ($66.8 billion); potential medical marijuana market will hit 35.7 billion Euros ($42.8 billion); potential recreational market value will reach 20.5 billion Euros ($24 billion); and the estimated hemp market will hit 48.9 million Euros ($57.2 billion). This is all without including the ancillary business and secondary market. The report notes that several European countries have passed medical marijuana legislation in the past couple of years, and there is a ‘50%’ chance a few countries could pass recreational laws in the next few years.”

Fact Sheet:

Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and  factors used in preparing the forward-looking information in this news release are reasonable,  undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed  time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Contact:

Richard Hylen, CEO

Tel:(530) 205-3437

 
EN
15/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Simlatus Corp

 PRESS RELEASE

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System SAN FRANCISCO, CA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a holding company currently focused on opportunities in the cannabis space that owns and operates a number of subsidiaries, all with multiple revenue streams, diversified in cannabis processing products, commercial broadcasting and support services to AT&T’s DirecTV products. Today the company announces that it has received another purchase order from United Opportunities LLC on ...

 PRESS RELEASE

SIML Proscere Bioscience Positions Long Term Strategy

SIML Proscere Bioscience Positions Long Term Strategy San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the company’s diver...

 PRESS RELEASE

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the com...

 PRESS RELEASE

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD...

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc. San Francisco, California, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’...

 PRESS RELEASE

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Ind...

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Industry With NASDAQ on the Horizon San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch